My Treatment Approach: My Treatment Approach: Navigating Genetic Testing and RET-Targeted Treatments in NSCLC - Episode 11

Monitoring Patients With RET-Positive NSCLC

,

Panelists discuss how to monitor patients for response to treatment and early signs of resistance in RET fusion–positive non–small cell lung cancer (NSCLC), including the approach to follow-up molecular testing, and describe strategies for treatment sequencing after disease progression on RET inhibitors.

EP. 1: Patient Case: 67 Year-Old Male With Stage IIIB+ NSCLC Awaiting for Mutation Testing
EP. 2: Next Steps to Stage IIIB NSCLC Patient Case Awaiting Molecular Testing and Usability of Liquid Biopsy
EP. 3: Testing Methodologies and Standards in Metastatic NSCLC
EP. 4: Practical Considerations in Metastatic NSCLC: Access and Timing of Testing
EP. 5: Clinical-Decision Making: When to Treat Advanced NSCLC Without Mutational Results
EP. 6: Initial Approach to Management of RET-Positive NSCLC
EP. 7: Patient and Therapy Considerations Guiding Initiation of Treatment in RET-Positive NSCLC
EP. 8: Considerations for First-Line Targeted Therapies in Metastatic RET-Positive NSCLC
EP. 9: Role of Immunotherapy and Chemotherapy in RET-Positive NSCLC
EP. 10: Managing RET Inhibitor Treatment-Related Adverse Events
Now Viewing
EP. 11: Monitoring Patients With RET-Positive NSCLC
EP. 12: Unmet Needs and Future Perspectives of RET-Positive NSCLC
  1. Dr Sands to Dr Wakelee: How do you monitor patients for response to treatment and early signs of resistance?
    1. What is your approach to follow-up molecular testing?
  2. Dr Wakelee: Describe your approach to treatment sequencing after disease progression on RET inhibitors.

Related Content:

My Treatment Approach: My Treatment Approach: Navigating Genetic Testing and RET-Targeted Treatments in NSCLC Video SeriesInsights
Unmet Needs and Future Perspectives of RET-Positive NSCLC
Future Considerations for Front-line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
Expert Perspectives: GALAXY Results from CIRUCLATE study - Is it Practice Changing?